NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
27 July 2024
| Name: | AVITA MEDICAL LTD (AVH) (This company subsequently changed its name to AVITA MEDICAL, INC. You should refer to that name for Status.) | ||||||||||||
| ISIN: | AU000000AVH4 | ||||||||||||
| Date of Listing: | 09 August 1993 | ||||||||||||
| Subsequent Names: |
| ||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to AVITA MEDICAL, INC. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 058 466 523ABN: 28 058 466 523
Registration Date: 21 December 1992
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now AVITA MEDICAL, INC. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| AVITA MEDICAL, INC | 21/01/2021 | |
| AVITA THERAPEUTICS INC | 29/06/2020 | 21/01/2021 |
| AVITA MEDICAL LTD | 26/06/2008 | 29/06/2020 |
| CLINICAL CELL CULTURE LIMITED | 12/11/2002 | 26/06/2008 |
| ECAT DEVELOPMENT CAPITAL LIMITED | 31/08/1999 | 12/11/2002 |
| GREENCHIP RESOURCES LIMITED | 31/08/1999 |
Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Avita Therapeutics Inc | 29/06/2020 |
The suspension of trading in the securities of Avita Medical Limited will be lifted immediately following the release of an announcement. ASX Code: AVH | 31/08/2015 |
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, has been given a high rating to its proposal to a U.S. federal body exploring the possible use of ReCell® under a disaster preparedness programme, the Company said today. | 31/08/2015 |
The securities of Avita Medical Corporation Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. Security Code: AVH | 28/08/2015 |
name changed from Clinical Cell Culture Limited | 26/06/2008 |
name changed to Avita Therapeutics Inc | 29/06/2020 |
The suspension of trading in the securities of Avita Medical Limited will be lifted immediately following the release of an announcement. ASX Code: AVH | 31/08/2015 |
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, has been given a high rating to its proposal to a U.S. federal body exploring the possible use of ReCell® under a disaster preparedness programme, the Company said today. | 31/08/2015 |
The securities of Avita Medical Corporation Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. Security Code: AVH | 28/08/2015 |
name changed from Clinical Cell Culture Limited | 26/06/2008 |
Your browser may reflect a date of printing in American format.
? | 25/12/2017 11:19:10 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 16/09/2020 | Michael Perry | -9,000 | $27.410 | $246,690 |
| 15/09/2020 | Michael Perry | -38,861 | $27.110 | $1,053,522 |
| 12/09/2020 | Michael Perry | -27,128 | $26.080 | $707,498 |
| 02/06/2020 | Michael Perry | -4,953,151 | $0.481 | $2,382,961 |
| 05/03/2020 | Michael Perry | -6,434,219 | $0.621 | $3,994,685 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Lou Panaccio | Chairman | 01/07/2014 |
| Troy Barring | COO | 20/06/2016 |
| David McIntyre | CFO | 18/11/2019 |
| Louis Drapeau | Non Exec Director | 13/01/2016 |
| Michael Perry | Non Exec Director, CEO | 06/02/2013 |
| Suzanne Crowe | Non Exec Director | 13/01/2016 |
| Jeremy Cook | Director | 19/10/2012 |
| Tim Rooney | Executive | |
| Mark Licciardo | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Damien McDonald | Non Exec Director | 13/01/2016 | 29/10/2020 |
| Dale Sander | CFO | 05/12/2017 | 15/05/2019 |
| Adam Kelliher | CEO | 14/04/2015 | 02/06/2017 |
| Fiona Wood | Non Exec Director | 11/04/2006 | 13/01/2016 |
| Ian Macpherson | Non Exec Director | 05/03/2008 | 13/01/2016 |
| Matthew McNamara | Director | 19/10/2012 | 13/01/2016 |
| Dalton Gooding | Non Exec Director | 14/11/2002 | 01/07/2014 |
| William Dolphin | Managing Director, CEO | 05/03/2008 | 15/12/2013 |
| Paul Watt | Director | 05/03/2008 | 19/10/2012 |
| Andrew Cannon | CFO | 31/12/2004 | 31/10/2008 |
| Marie Stoner | Non Exec Director | 19/12/2002 | 15/02/2008 |
| Mark Barnaba | Non Exec Director | 30/03/2005 | 14/02/2008 |
| Bob Atwill | CEO | 17/05/2006 | 29/03/2007 |
| Troels Jordansen | CEO | 01/01/2003 | 16/05/2006 |
| David Imperiali | Non Exec Director | 03/05/2004 | 11/04/2006 |
| Harry Karelis | Non Exec Director | 14/08/2003 | 25/10/2004 |
| Paul Fletcher | Non Exec Director | 14/11/2002 | 29/05/2004 |
| Philip Rees | Executive Director | 31/07/2003 | |
| Peter Constable | Non Exec Director | 14/11/2002 | 08/07/2003 |
| Ludger Kohmascher | Chairman | 16/09/1999 | 14/11/2002 |
| Adam Rankine-Wilson | Managing Director | 14/11/2002 | |
| David Archer | Chairman | 16/09/1999 | 07/03/2002 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
